Pathophysiology of Anemia in HIV-Infected Children Exposed to Malaria.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
18 01 2021
Historique:
received: 23 10 2019
accepted: 24 09 2020
pubmed: 4 2 2021
medline: 15 2 2022
entrez: 3 2 2021
Statut: epublish

Résumé

Anemia is a common condition in HIV-infected children; however, its pathophysiology and the contribution of frequent causes of anemia such as iron deficiency (ID) and malaria are poorly understood. We carried out an ancillary study on the effect of HIV on anemia as part of a case-control study on risk factors of anemia among Mozambican children aged 1-59 months with documented HIV status. Of them, 390 children were admitted to the hospital with anemia (hemoglobin [Hb] < 11 g/dL), whereas 272 children without anemia (Hb ≥ 11 g/dL) were recruited in the community. We assessed differences by HIV status in the presentation of anemia etiological factors and the effect of HIV infection on the association of each factor with anemia. Among the 99 HIV-infected and 563 uninfected children included, HIV-infected anemic children had an increased risk of undernutrition (P < 0.0001), Epstein-Barr virus infection (P < 0.0001), bacteremia (P = 0.0060), a decreased risk of malaria (P < 0.0001), and a similar risk of ID (P = 0.7371) compared with anemic-uninfected children. HIV-infected children were significantly less likely to have anemia associated with Plasmodium falciparum hyperparasitemia (P = 0.0444) and had a lower prevalence of parasitemia in the bone marrow (BM) (P < 0.0001) than anemic-uninfected children. Levels of BM erythropoiesis and dyserythropoiesis were comparable between groups. These findings suggest that the pathophysiology of anemia among HIV-infected malaria-exposed children is not related to HIV-specific effects. For unclear reasons, HIV-infected children had reduced risk of malaria infection, whereas ID prevalence was comparable in HIV-infected and uninfected children, suggesting that iron supplementation recommendations should not be different in HIV-infected children.

Identifiants

pubmed: 33534758
doi: 10.4269/ajtmh.19-0783
pii: tpmd190783
pmc: PMC7941855
doi:
pii:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1003-1012

Subventions

Organisme : Howard Hughes Medical Institute
Pays : United States

Auteurs

Cinta Moraleda (C)

1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
2Manhiça Health Research Center (CISM), Manhiça, Mozambique.

Ruth Aguilar (R)

1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
2Manhiça Health Research Center (CISM), Manhiça, Mozambique.
3CIBER Epidemiology and Public Health (CIBERESP), Barcelona, Spain.

Llorenç Quintó (L)

1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Tacilta Nhampossa (T)

2Manhiça Health Research Center (CISM), Manhiça, Mozambique.

Montserrat Renom (M)

1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
2Manhiça Health Research Center (CISM), Manhiça, Mozambique.

Augusto Nhabomba (A)

2Manhiça Health Research Center (CISM), Manhiça, Mozambique.

María Ruperez (M)

1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
2Manhiça Health Research Center (CISM), Manhiça, Mozambique.

John J Aponte (JJ)

1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
2Manhiça Health Research Center (CISM), Manhiça, Mozambique.

Ariel H Achtman (AH)

4Walter and Eliza Hall Institute for Medical Research, Victoria, Australia.
5Department of Medical Biology, The University of Melbourne, Victoria, Australia.

María Del Mar Mañú Pereira (MDM)

6Red Blood Cell Pathology- Centre for Rare Diseases, Vall d'Hebron Research Institute, University Hospital Vall d'Hebron, Barcelona, Spain.

Louis Schofield (L)

4Walter and Eliza Hall Institute for Medical Research, Victoria, Australia.
5Department of Medical Biology, The University of Melbourne, Victoria, Australia.
7Australian Institute of Tropical Health and Medicine, James Cook University, Douglas, Australia.

Pedro L Alonso (PL)

1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
2Manhiça Health Research Center (CISM), Manhiça, Mozambique.

Eusebio Macete (E)

2Manhiça Health Research Center (CISM), Manhiça, Mozambique.
8National Directorate of Health, Ministry of Health, Maputo, Mozambique.

Clara Menéndez (C)

1ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
2Manhiça Health Research Center (CISM), Manhiça, Mozambique.
3CIBER Epidemiology and Public Health (CIBERESP), Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH